Despite LifeTech Scientific's share price drop, its high P/E ratio suggests investors expect outperformance. However, its lower-than-market growth forecast could risk further price decline and a lower P/E ratio, potentially endangering shareholders' investments and causing potential investors to pay a high premium.
先健科技に関するコメント
CIMB: Lifetech Scientific Corp (1302)の技術的買い - Alpha Edge Investing
$先健科技 (01302.HK)$
まだコメントはありません